Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 3/20 | 0.60 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.60 |
| ▸ | CYP19A1 | P11511 | 10/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.47 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.47 |
| ▸ | CCKBR | P32239 | 2/20 | 0.47 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.47 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.47 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.47 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL332630 | 0.78 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP19A1NR1I2ADORA3 | |
| SCHEMBL25312529 | 0.77 | CYP11B1 (0.73) | CYP11B1CYP11B2CYP19A1NR1I2ADORA3 | |
| SCHEMBL30698274 | 0.77 | CYP11B1 (0.58) | CYP11B1CYP11B2CYP19A1NR1I2ADORA3 | |
| Methyl Alcohol SCHEMBL27766624 | 0.76 | CYP11B1 (0.89) | CYP11B1CYP11B2CYP19A1NR1I2ADORA3 | |
| SCHEMBL5738206 | 0.75 | CYP11B1 (0.80) | CYP11B1CYP11B2CYP19A1NR1I2ADORA3 | |
| Propionaldehyde SCHEMBL7622939 | 0.74 | CYP11B1 (0.73) | CYP11B1CYP11B2CYP19A1NR1I2ADORA3 | |
| SCHEMBL12199510 | 0.73 | CYP11B1 (0.89) | CYP11B1CYP11B2CYP19A1NR1I2ADORA3 | |
| Formaldehyde SCHEMBL27502810 | 0.73 | CYP11B1 (0.89) | CYP11B1CYP11B2CYP19A1NR1I2ADORA3 | |
| SCHEMBL10896782 | 0.72 | CYP11B1 (0.60) | CYP11B1CYP11B2CYP19A1NR1I2ADORA3 | |
| SCHEMBL5437850 | 0.72 | CYP11B1 (0.80) | CYP11B1CYP11B2CYP19A1NR1I2ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117157303-A | Analogs of CDDO-2P-IM and CDDO-3P-IM | 三萜系化合物治疗公司 | 2023-12-01 | — | — | CN | disclosed |
| US-20230365621-A1 | ANALOGS OF CDDO-2P-IM AND CDDO-3P-IM | TRITERPENOID THERAPEUTICS INC (US) | 2023-11-16 | — | — | US | disclosed |
| CN-115996925-A | Capsid inhibitors for the treatment of HIV | 吉利德科学公司 | 2023-04-21 | — | — | CN | disclosed |
| EP-2969007-A1 | HISTONE DEMETHYLASE INHIBITORS | Quanticel Pharmaceuticals Inc (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014151945-A1 | HISTONE DEMETHYLASE INHIBITORS | Quanticel Pharmaceuticals, Inc. (US) | 2014-09-25 | — | — | WO | disclosed |
| EP-1333834-A4 | ANTIINFLAMMATION AGENTS | AMGEN INC (US) | 2007-01-17 | — | — | EP | disclosed |
| EP-1333834-A2 | ANTIINFLAMMATION AGENTS | Tularik Inc. (US) | 2003-08-13 | — | — | EP | disclosed |
| WO-2002041843-A2 | ANTIINFLAMMATION AGENTS | TULARIK INC. (US) | 2002-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365621-A1 | ANALOGS OF CDDO-2P-IM AND CDDO-3P-IM | CDYL2, CYP11B2, HSD17B13 | CYP11B1 6/4885CYP11B2 2/4885CYP19A1 429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.